Rozanolixizumab as rescue therapy in triple-seronegative refractory generalized myasthenia gravis
Immunol Med. 2025 Nov 10:1-6. doi: 10.1080/25785826.2025.2582274. Online ahead of print. ABSTRACT Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction, most commonly …